Brief: Annexin Pharmaceuticals Carries Out Directed Share Issue Of About SEK 7 Mln
Dec 19 (Reuters) - Annexin Pharmaceuticals AB (publ)
ANNX.ST :
* ANNEXIN PHARMACEUTICALS CARRIES OUT A DIRECTED SHARE ISSUE
OF
APPROXIMATELY SEK 7 MILLION TO BEGIN DEVELOPMENT IN THE CANCER
FIELD
* SUBSCRIPTION PRICE OF SEK 0.95 PER SHARE
Source text for Eikon: ID:nWkr2FCD9H
Further company coverage: ANNX.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com;))
Recent news on Annexin Pharmaceuticals AB (publ)
See all newsBrief: Annexin Pharmaceuticals Q3 Net Loss At SEK 9.5 Mln
Brief: Annexin Pharmaceuticals Q2 2026 Net Loss SEK 11.6 Mln
Brief: Annexin Pharmaceuticals Gets International Nonproprietary Name Drug Candidate Anxv
Brief: Annexin Pharmaceuticals Updates On Nine Patients Treated In Nexus Study
Brief: Annexin's Rights Issue 98% Subscribed